VANCOUVER, June 8 /CNW/ - ALDA Pharmaceuticals Corp. (APH:TSX-V) (the
"Company") is pleased to announce that it has negotiated a non-brokered
private placement of 1,100,000 units of the Company (the "Units") at a price
of $0.05 per Unit for proceeds to the Company of $55,000. Each Unit consists
of one common share of ALDA and one non-transferable share purchase warrant
entitling the holder to acquire one additional common share of ALDA at a price
of $0.10 per common share for a period of twelve (12) months from the date of
the issuance of the purchase warrant. Terrance Owen, the Company's Chief
Executive Officer and a director, has subscribed for 20,000 Units of this
private placement.
